Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seasonal malaria chemoprevention in children in Turkana
PACTR202405701724013Not yet recruiting
- Sponsor
- Moi University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sulfadoxine + pyrimethamine and amodiaquine in malaria (2 arms), sponsored by Moi University. Primary endpoint: Incidence of symptomatic malaria infection. Planned start May 2024; status: not yet recruiting.
02
Drugs
sulfadoxine + pyrimethamineamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202405701724013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202405701724013.